Aliases & Classifications for Mouth Disease

Aliases & Descriptions for Mouth Disease:

Name: Mouth Disease 12 29 14
Mouth Diseases 42 69
Mouth Disorders 41

Classifications:



External Ids:

Disease Ontology 12 DOID:403
MeSH 42 D009059
NCIt 47 C27641 C3240
UMLS 69 C0026636

Summaries for Mouth Disease

MedlinePlus : 41 your mouth is one of the most important parts of your body. any problem that affects your mouth can make it hard to eat, drink or even smile. some common mouth problems include cold sores - painful sores on the lips and around the mouth, caused by a virus canker sores - painful sores in the mouth, caused by bacteria or viruses thrush - a yeast infection that causes white patches in your mouth leukoplakia - white patches of excess cell growth on the cheeks, gums or tongue, common in smokers dry mouth - a lack of enough saliva, caused by some medicines and certain diseases gum or tooth problems bad breath treatment for mouth disorders varies, depending on the problem. keeping a clean mouth by brushing and flossing often is important.

MalaCards based summary : Mouth Disease, also known as mouth diseases, is related to hepatitis and burns, and has symptoms including coughing, halitosis and oral manifestations. An important gene associated with Mouth Disease is IL6 (Interleukin 6), and among its related pathways/superpathways are Innate Immune System and TGF-Beta Pathway. The drugs Metronidazole and sodium fluoride have been mentioned in the context of this disorder. Affiliated tissues include tongue, testes and t cells, and related phenotypes are hematopoietic system and mortality/aging

Disease Ontology : 12 A gastrointestinal system disease that is located in the mouth.

Related Diseases for Mouth Disease

Diseases related to Mouth Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 147)
id Related Disease Score Top Affiliating Genes
1 hepatitis 30.0 IFNG IL10 IL6
2 burns 29.7 IFNG IL10 IL6
3 tuberculosis 29.7 IL10 IL1B IL6
4 hand, foot and mouth disease 12.3
5 burning mouth syndrome 10.8
6 oral hairy leukoplakia 10.5
7 cyclosporiasis 10.4 IFNG IL10 IL6
8 multiple mitochondrial dysfunctions syndrome 10.4 IFNG IL10 IL6
9 conduct disorder 10.4 IFNG IL10 IL6
10 pancreatic signet ring cell adenocarcinoma 10.4 IFNG IL10 IL6
11 hereditary alpha tryptasemia syndrome 10.4 IFNG IL10 IL6
12 erb-duchenne and dejerine-klumpke palsies 10.4 IFNG IL10 IL6
13 usher syndrome, type 2a 10.3 IFNG IL10 IL6
14 orbital osteomyelitis 10.3 IFNG IL10 IL6
15 hutchinson incisors 10.3 IFNG PTBP1 STAT1
16 disease of mental health 10.3 IFNG IL10 IL6
17 follicular adenoma 10.3 IFNG IL10 IL6
18 childhood electroclinical syndrome 10.3 IL10 IL1B IL6
19 hypoparathyroidism-retardation-dysmorphism syndrome 10.3 IL10 IL1B IL6
20 myiasis 10.3 IFNG IL10 IL6
21 parkinson disease 11 10.3 IFNG IL10 IL1B
22 rosacea 10.3 IFNG IL10 IL1B
23 rheumatoid factor-negative juvenile idiopathic arthritis without anti-nuclear antibodies 10.3 IL10 IL1B IL6
24 gonococcal endophthalmia 10.3 IL10 IL1B IL6
25 senile reticular retinal degeneration 10.3 IFNG IL10 IL1B
26 urea cycle disorder 10.3 IL10 IL1B IL6
27 autosomal recessive type iv ehlers-danlos syndrome 10.3 IL10 IL1B IL6
28 ethmoid sinus cancer 10.3 IFNG IL1B STAT1
29 rickettsialpox 10.3 IFNG IL10 IL1B
30 inappropriate adh syndrome 10.3 IL10 IL1B IL6
31 oral cavity carcinoma in situ 10.3 IFNG IL10 IL1B
32 causalgia 10.3 IFNG IL10 IL6
33 depressed scar 10.3 IFNG IL10 IL6 STAT1
34 skin benign neoplasm 10.3 IFNA1 IL10 STAT1
35 central nervous system lymphoma 10.3 IL10 IL1B IL6
36 labyrinthitis 10.3 IL10 IL1B IL6
37 heart conduction disease 10.3 IFNG IL10 STAT1
38 mansonelliasis 10.3 IFNG IL10 IL6
39 atrophy of prostate 10.3 IL10 IL1B IL6
40 plummer's disease 10.3 IFNG IL10 IL6 VTN
41 chronic gonorrhea of cervix 10.3 IFNG IL10 IL17F STAT1
42 motor peripheral neuropathy 10.3 IFNG IL10 STAT1
43 immunoglobulin g deficiency 10.3 IL10 IL1B IL6
44 breast reconstruction 10.3 IL10 IL1B IL6
45 isolated growth hormone deficiency 10.3 IFNG IL1B STAT1
46 mineral metabolism disease 10.3 IL1B IL6 OAS1
47 chordoid meningioma 10.3 IL10 IL1B IL6
48 ectodermal dysplasia bartalos type 10.3 IFNG IL10 IL1B IL6
49 choroiditis 10.3 IL10 IL1B IL6
50 classic type lipoma 10.3 IFNG IL10 IL1B IL6

Graphical network of the top 20 diseases related to Mouth Disease:



Diseases related to Mouth Disease

Symptoms & Phenotypes for Mouth Disease

UMLS symptoms related to Mouth Disease:


coughing, halitosis, oral manifestations, snoring, sore throat, vertigo/dizziness, equilibration disorder

MGI Mouse Phenotypes related to Mouth Disease:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.9 IFNG IL10 IL17F IL1B IL6 ITGAV
2 mortality/aging MP:0010768 9.77 ANKRD17 FUBP1 IFNG IL10 IL17F IL1B
3 skeleton MP:0005390 9.28 PAX9 PTBP1 STAT1 IFNG IL10 IL17F

Drugs & Therapeutics for Mouth Disease

Drugs for Mouth Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1467)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Metronidazole Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 443-48-1 4173
2 sodium fluoride Approved Phase 4,Phase 3,Phase 1,Phase 2 7681-49-4
3
Triclosan Approved Phase 4,Phase 3,Phase 1,Phase 2 3380-34-5 5564
4
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 564-25-0 54671203
5
Levonorgestrel Approved, Investigational Phase 4,Phase 2,Phase 3 797-63-7, 17489-40-6 13109
6
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 26787-78-0 33613 2171
7
Epinephrine Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 51-43-4 5816
8
Chlorhexidine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Early Phase 1 55-56-1 9552079 2713
9
Hexetidine Approved Phase 4 141-94-6
10
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
11
Acetaminophen Approved Phase 4,Phase 2,Phase 3,Phase 1 103-90-2 1983
12
Aminocaproic Acid Approved, Investigational Phase 4,Phase 3 60-32-2 564
13
Lidocaine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 137-58-6 3676
14
Benzocaine Approved Phase 4,Phase 3,Phase 2,Phase 1 1994-09-7, 94-09-7 2337
15
Donepezil Approved Phase 4,Phase 3,Phase 2,Phase 1 120014-06-4 3152
16
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 51-61-6, 62-31-7 681
17
Memantine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 19982-08-2 4054
18
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 83-43-2 6741
19
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-24-8 5755
20
Fluocinolone Acetonide Approved, Investigational, Vet_approved Phase 4 67-73-2 6215
21
Docosanol Approved, Investigational Phase 4 30303-65-2, 661-19-8 12620
22
Sucralfate Approved Phase 4,Phase 3 54182-58-0
23
Calcium carbonate Approved Phase 4,Phase 1 471-34-1
24
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 50-18-0, 6055-19-2 2907
25
Cyclosporine Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 79217-60-0, 59865-13-3 5284373 6435893
26
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 53-03-2 5865
27
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-78-2 2244
28
Phenprocoumon Approved Phase 4,Phase 3 435-97-2 9908 54680692
29
Ticlopidine Approved Phase 4,Phase 3,Phase 2,Phase 1 55142-85-3 5472
30
Warfarin Approved Phase 4,Phase 2,Phase 3,Phase 1 81-81-2 6691 54678486
31
Insulin Glargine Approved Phase 4,Phase 3 160337-95-1
32
Metformin Approved Phase 4,Phase 2,Phase 3,Phase 1 657-24-9 14219 4091
33
Zinc Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 7440-66-6 32051 23994
34
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-28-2 5757 53477783
35
Norethindrone Approved Phase 4,Phase 2,Phase 1 68-22-4 6230
36
Citalopram Approved Phase 4,Phase 2,Phase 3,Phase 1 59729-33-8 2771
37
Clarithromycin Approved Phase 4,Phase 2,Phase 3,Phase 1 81103-11-9 84029
38
Clofazimine Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 2030-63-9 2794
39
Rifabutin Approved Phase 4,Phase 3 72559-06-9 6323490
40
Azithromycin Approved Phase 4,Phase 3,Phase 2,Phase 1 83905-01-5 55185 53477736 447043
41
Dronabinol Approved, Illicit Phase 4,Phase 2,Phase 1 1972-08-3 16078 2978
42
Ciclopirox Approved, Investigational Phase 4 29342-05-0 2749
43
Isotretinoin Approved Phase 4,Phase 1 4759-48-2 5538 5282379
44
Salicylic acid Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 69-72-7 338
45
Iloprost Approved, Investigational Phase 4,Phase 3,Phase 2 78919-13-8 6443959
46
Menthol Approved Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1 2216-51-5 16666
47
Minocycline Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 10118-90-8 5281021
48
Ciprofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 85721-33-1 2764
49
Hyaluronic acid Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 9004-61-9 53477741 24759
50
Ethanol Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 64-17-5 702

Interventional clinical trials:

(show top 50) (show all 5000)
id Name Status NCT ID Phase
1 The Treatment of Periodontal Diseases Unknown status NCT01318928 Phase 4
2 Clinical Investigation of the Effects of Colgate Total Toothpaste as Compared to a Matching Placebo on Periodontal Disease and Systemic Inflammatory Markers Unknown status NCT02670135 Phase 4
3 Effect of Actonel on Periodontal Health of Postmenopausal Women Unknown status NCT00594334 Phase 4
4 Clinical and Microbiological Effects of an Essential Oils Solution Used as an Adjunct to Daily Oral Hygiene Practices in Chronic Periodontitis Patients in Supportive Care Unknown status NCT01195493 Phase 4
5 Norplant and Irregular Bleeding/Spotting Unknown status NCT00064766 Phase 4
6 Metronidazole and Amoxicillin for the Treatment of Type 2 Diabetic Subjects With Periodontitis Unknown status NCT02135952 Phase 4
7 Evaluation of Photodynamic Treatment FOTOSAN® Efficacy in Periodontology Unknown status NCT02030470 Phase 4
8 Manually Versus Digitally Fabricated Removable Partial Dentures Unknown status NCT01191073 Phase 4
9 Clinical, Microbiological and Biochemical Effects of the Antimicrobial Photodynamic Therapy Unknown status NCT01532674 Phase 4
10 Study of Scaling and Root Planing With PerioWave Versus Scaling and Root Planing Alone in Chronic Periodontitis Unknown status NCT00297531 Phase 4
11 SRP in Combination With PERIOWAVE in Comparison to SRP Alone in Chronic Periodontitis Unknown status NCT00296881 Phase 4
12 Methodology Antiseptic Application, Influence on Oral Biofilm. Unknown status NCT02267239 Phase 4
13 Evaluation of a Lateral Window Technique Augmentation for Maxillary Sinus Using Ultrasound Activated Pins Unknown status NCT02449707 Phase 4
14 Randomized Clinical Trial With Aminocaproic Acid in the Prevention of Exodontic Bleeding in Anticoagulants Patients Unknown status NCT02238288 Phase 4
15 Diagnosis of Oral Precancers and Cancers Using Optic Coherence Tomography Unknown status NCT00172965 Phase 4
16 Connective Tissue Graft Versus Mucograft Collagen Matrix for Coverage of Multiple Gingival Recession Defects Unknown status NCT01440426 Phase 4
17 Platelet Rich Fibrin in the Treatment of Palatal Wounds Unknown status NCT02438046 Phase 4
18 Effect of Memantine Oral Pump on Language in Patients With Probable Alzheimer's Disease Unknown status NCT01849042 Phase 4
19 The Efficacy of Methylprednisolone in the Treatment of Patients With Ocular Involvement in Behcet's Disease Unknown status NCT01306955 Phase 4
20 Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 Mcg BID Unknown status NCT00235053 Phase 4
21 Adhesion of Connective Tissue Around Laser-treated Abutments for Dental Implants - Clinical Trial in Humans Unknown status NCT01954485 Phase 4
22 Anticaries Effect of Probiotic Lactobacillus Brevis CD2 (Lb CD2). Unknown status NCT01778699 Phase 4
23 Flucinolone Acetonide Implant for Treating Refractory Ocular Behcet's Disease Unknown status NCT00720928 Phase 4
24 Comparison of Topical Antiviral Agents for Labial Cold Sores (Herpes Labialis) Unknown status NCT00467662 Phase 4
25 Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases Unknown status NCT01151644 Phase 4
26 ZeroTolerance Mucositis: Managing Oral and Alimentary Mucositis With High Potency Sucralfate - ProThelial Unknown status NCT02016807 Phase 4
27 Sex Steroids in Sjögren's Syndrome: Effect of Substitution Treatment on Fatigue Unknown status NCT00543166 Phase 4
28 Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's Syndrome Unknown status NCT02370550 Phase 4
29 Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors Unknown status NCT00777504 Phase 4
30 A Trial to Evaluate Efficacy of Heart-protecting Musk Pill Unknown status NCT01897805 Phase 4
31 An Efficacy Study of BCS Clearing the Oral Colonized Bacterium in Hospitalized Patients With COPD Unknown status NCT02269800 Phase 4
32 Anti-proteinuric Effect of Calcitriol in Non-diabetic Kidney Disease Patients Unknown status NCT01512862 Phase 4
33 Periodontal Therapy in Coronary Artery Patients Unknown status NCT01609725 Phase 4
34 Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation Unknown status NCT00776633 Phase 4
35 Can Insulin Glargine Improve Myocardial Function in Patients With T2D and Coronary Artery Disease (CAD) Unknown status NCT01035528 Phase 4
36 Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy Unknown status NCT02264743 Phase 4
37 Oral Calcitriol for Reduction of Mild Proteinuria in Patients With CKD Unknown status NCT01820832 Phase 4
38 Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder (MDD) Unknown status NCT01483053 Phase 4
39 Oral Versus Intravenous Antibiotics for Bone and Joint Infections (OVIVA B&J) Unknown status NCT00974493 Phase 4
40 Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function Unknown status NCT01825759 Phase 4
41 Treatment of Crohn's Disease With an Antibiotic Regimen Directed Against Mycobacterium Avium Paratuberculosis Unknown status NCT00513552 Phase 4
42 The Efficacy of Prednisone and Azithromycin in the Treatment of Patients With Cat Scratch Disease Unknown status NCT01469702 Phase 4
43 Add on Study on Δ9-THC Treatment for Posttraumatic Stress Disorders (PTSD) Unknown status NCT00965809 Phase 4
44 Efficacy and Safety of Low-dose Oral Isotretinoin for Seborrhea Unknown status NCT01139749 Phase 4
45 Effects of Iloprost Treatment in Adult Patients With Pulmonary Arterial Hypertension Related to Congenital Heart Disease Unknown status NCT01383083 Phase 4
46 Regenerative Surgical Treatment of Peri-implantitis Completed NCT02500654 Phase 4
47 Locally Delivered Doxycycline Adjunct to Nonsurgical Periodontal Therapy. Completed NCT02487186 Phase 4
48 Conventional or Minimally Invasive Surgical Technique for the Treatment of Furcation Defects Using Enamel Matrix Derivative and Anorganic Bovine Bone - a Randomized Controlled Clinical Trial. Completed NCT02102360 Phase 4
49 EMD and/or Bone Substitute for the Treatment of Class II Furcations Completed NCT02474498 Phase 4
50 Pediatric Study to Access Pharmacokinetics and Safety of Oraqix Gel Completed NCT01591616 Phase 4

Search NIH Clinical Center for Mouth Disease

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: mouth diseases

Genetic Tests for Mouth Disease

Genetic tests related to Mouth Disease:

id Genetic test Affiliating Genes
1 Abnormality of the Mouth 29

Anatomical Context for Mouth Disease

MalaCards organs/tissues related to Mouth Disease:

39
Tongue, Testes, T Cells, Skin, Kidney, B Cells, Liver

The Foundational Model of Anatomy Ontology organs/tissues related to Mouth Disease:

18
The Mouth

Publications for Mouth Disease

Articles related to Mouth Disease:

(show top 50) (show all 837)
id Title Authors Year
1
Proximal onycholysis as a complication of hand, foot, and mouth disease. ( 28083877 )
2017
2
The exposure-response relationship between temperature and childhood hand, foot and mouth disease: A multicity study from mainland China. ( 28069250 )
2017
3
Temporal and spatial analysis of hand, foot, and mouth disease in relation to climate factors: A study in the Mekong Delta region, Vietnam. ( 28063653 )
2017
4
Development of a Feature and Template-Assisted Assembler and Application to the Analysis of a Foot-and-Mouth Disease Virus Genotyping Microarray. ( 28045937 )
2017
5
A Case-control Study on Risk Factors for Severe Hand, Foot and Mouth Disease. ( 28084311 )
2017
6
Nonlinear and Interactive Effects of Temperature and Humidity on Childhood Hand, Foot and Mouth Disease in Hefei, China. ( 27276180 )
2016
7
Foot-and-mouth disease virus-like particles as integrin-based drug delivery system achieve targeting anti-tumor efficacy. ( 27993721 )
2016
8
Molecular epidemiology of the enteroviruses associated with hand, foot and mouth disease/herpangina in Dongguan, China, 2015. ( 27654666 )
2016
9
Study of the epidemiology and etiological characteristics of hand, foot, and mouth disease in Suzhou City, East China, 2011-2014. ( 27146138 )
2016
10
Complete Genome Sequences of Three African Foot-and-Mouth Disease Viruses from Clinical Samples Isolated in 2009 and 2010. ( 27151795 )
2016
11
Development and evaluation of a non-ribosomal random PCR and next-generation sequencing based assay for detection and sequencing of hand, foot and mouth disease pathogens. ( 27388326 )
2016
12
DNA vaccine (P1-2A-3C-pCDNA) co-administered with Bovine IL-18 gives protective immune response against Foot and Mouth Disease in cattle. ( 27599937 )
2016
13
Protection of a novel epitope-RNA VLP double-effective VLP vaccine for foot-and-mouth disease. ( 27565990 )
2016
14
Socio-ecological factors and hand, foot and mouth disease in dry climate regions: a Bayesian spatial approach in Gansu, China. ( 27329324 )
2016
15
Seroprevalence of Foot-and-Mouth Disease in Susceptible Wildlife in Israel. ( 27200364 )
2016
16
Determinants of the Transmission Variation of Hand, Foot and Mouth Disease in China. ( 27701445 )
2016
17
Early Decision Indicators for Foot-and-Mouth Disease Outbreaks in Non-Endemic Countries. ( 27965969 )
2016
18
The costs of preventive activities for exotic contagious diseases-A Danish case study of foot and mouth disease and swine fever. ( 27544260 )
2016
19
Both Cis- and Trans- Activities of the Foot-and-Mouth Disease Virus 3D Polymerase are Essential for Viral RNA Replication. ( 27194768 )
2016
20
Epidemiological Features of Hand, Foot and Mouth Disease during the Period of 2008-14 in Wenzhou, China. ( 27765889 )
2016
21
Analysis of factors associated with hesitation to restart farming after depopulation of animals due to 2010 foot-and-mouth disease epidemic in Japan. ( 27149890 )
2016
22
Prolonged Breastfeeding Is Associated With Lower Risk Of Severe Hand, Foot And Mouth Disease In Chinese Children. ( 26650113 )
2016
23
Foot-and-Mouth Disease Virus-Associated Abortion and Vertical Transmission following Acute Infection in Cattle under Natural Conditions. ( 27977708 )
2016
24
Cost-benefit analysis of foot and mouth disease control in Ethiopia. ( 27664449 )
2016
25
Changes of circulating Th22 cells in children with hand, foot, and mouth disease caused by enterovirus 71 infection. ( 28030850 )
2016
26
Transcriptomic Analysis of Persistent Infection with Foot-and-Mouth Disease Virus in Cattle Suggests Impairment of Apoptosis and Cell-Mediated Immunity in the Nasopharynx. ( 27643611 )
2016
27
An Outbreak of Kingella kingae Infections Complicating a Severe Hand, Foot, And Mouth Disease Outbreak in Nice, France, 2016. ( 28002358 )
2016
28
Early risk indicators for hand, foot and mouth disease clusters in China. ( 27684557 )
2016
29
Chimeric foot-and-mouth disease virus serotype O displaying a serotype Asia1 antigenic epitope at the surface. ( 27160994 )
2016
30
The Effects of Weather Factors on Hand, Foot and Mouth Disease in Beijing. ( 26755102 )
2016
31
Hand, Foot and Mouth Disease in Hong Kong: A Time-Series Analysis on Its Relationship with Weather. ( 27532865 )
2016
32
Hand Foot and Mouth Disease Like Illness in Office Practice. ( 27943150 )
2016
33
Short-term effects of meteorological factors on hand, foot and mouth disease among children in Shenzhen, China: Non-linearity, threshold and interaction. ( 26386448 )
2016
34
A literature review and case report of hand, foot and mouth disease in an immunocompetent adult. ( 26975350 )
2016
35
Construction of Stabilized and Tagged Foot-and-Mouth Disease Virus. ( 27659244 )
2016
36
In-cell SHAPE uncovers dynamic interactions between the untranslated regions of the foot-and-mouth disease virus RNA. ( 27608725 )
2016
37
EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD). ( 26732723 )
2016
38
Genomics and outbreaks: foot and mouth disease. ( 27217177 )
2016
39
Hand, foot and mouth disease: an overview of clinical features in adult patients. ( 27859744 )
2016
40
Two Genotypes of Coxsackievirus A2 Associated with Hand, Foot, and Mouth Disease Circulating in China since 2008. ( 28030650 )
2016
41
Enterovirus-related diarrhoea in Guangdong, China: clinical features and implications in hand, foot and mouth disease and herpangina. ( 26983856 )
2016
42
Diagnostic uncertainty of herpangina and hand-foot-and-mouth disease and its impact on national enterovirus syndromic monitoring. ( 26593706 )
2016
43
Neurological complications and risk factors of cardiopulmonary failure of EV-A71-related hand, foot and mouth disease. ( 27001010 )
2016
44
Age patterns and transmission characteristics of hand, foot and mouth disease in China. ( 27871252 )
2016
45
Effects of Meteorological Parameters and PM10 on the Incidence of Hand, Foot, and Mouth Disease in Children in China. ( 27171104 )
2016
46
Enhanced immune response to foot-and-mouth disease vaccine by oral administration of ginseng stem-leaf saponins. ( 27216768 )
2016
47
Ambulatory Pediatric Surveillance of Hand, Foot and Mouth Disease as Signal of an Outbreak of Coxsackievirus A6 Infections, France, 2014-2015. ( 27767012 )
2016
48
Immunodominant IgM and IgG Epitopes Recognized by Antibodies Induced in Enterovirus A71-Associated Hand, Foot and Mouth Disease Patients. ( 27806091 )
2016
49
Diagnosis of human enteroviruses that cause hand, foot and mouth disease. ( 27042876 )
2016
50
Clinicopathologic analysis of atypical hand, foot, and mouth disease in adult patients. ( 28027826 )
2016

Variations for Mouth Disease

Expression for Mouth Disease

Search GEO for disease gene expression data for Mouth Disease.

Pathways for Mouth Disease

Pathways related to Mouth Disease according to GeneCards Suite gene sharing:

(show all 46)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
14.02 EIF4G1 EIF4G3 IFNA1 IFNG IL10 IL17F
2
Show member pathways
13.53 EIF4G1 EIF4G3 IFNA1 IFNG IL10 IL1B
3
Show member pathways
12.9 IFNA1 IFNG IL10 IL1B IL6 STAT1
4
Show member pathways
12.81 EIF4G1 EIF4G3 IFNA1 IFNG IL10 IL17F
5
Show member pathways
12.77 IFNA1 IFNG IL1B IL6 MX1 OAS1
6
Show member pathways
12.66 EIF4G1 EIF4G3 IFNA1 IFNG IL10 IL1B
7
Show member pathways
12.59 IFNG IL10 IL17F IL1B IL6 STAT1
8 12.58 EIF4B IFNA1 IL6 ITGAV VTN
9
Show member pathways